Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease.


Studies of cerebrospinal fluid (CSF) biomarkers in Alzheimer's disease (AD) have indicated that much of the variability observed in the biomarkers may be due to measurement error. Biomarkers are often obtained with measurement error, which may make the diagnostic biomarker appear less effective than it truly is. In the Alzheimer's Disease Neuroimaging… (More)
DOI: 10.3233/JAD-151045


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics